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Abstract
Background: With the invention of the ion-selective electrode (ISE), ionic magnesium (iMg) is a
common blood assay. This could be advantageous, as iMg is the biologically active form of Mg.
There is some evidence that iMg has considerable within subject variability.
Results: Individual ranges averaged .08 mmol/L (range .05 to .14). Coefficients of variation (CV)
ranged from 3% to 7% (mean 4%) while analytical variation was determined to be 2.3%. Biological
variability thus accounts for almost half of the variability, which is clinically significant, as 9 of the 13
subjects recorded at least one value below a reference range of .46 – .60 mmol/L. A significant
within-day variation (p < .001) was noted, with differences between 7:00 and 10:00 as well as 10:00
and 22:00. Between day variations were not significant (p = .56).
Conclusions: A plausible explanation of this data is that iMg has a circadian rhythm. Thus, cautious
interpretation of single iMg values is warranted until future research determines the nature of iMg
variability.
Background
Advances in ionic sensitive electrode (ISE) technology has
allowed ionic magnesium (iMg) to become a common
measure of Mg status. However, some evidence has shown
that iMg may be quite variable and thus not a reliable
measure. The primary purpose of this study was to analyze
the variability of iMg to determine if it is a reliable meas-
ure. If iMg is variable, a secondary purpose was to deter-
mine if a diurnal pattern exists over the course of three
days.
The rationale for studying the variability of iMg lies in the
physiological importance of magnesium, the prevalence
of Mg deficiencies and the emergence of iMg as a poten-
tially sensitive measure of Mg status. The usefulness of
iMg in both clinical or research settings hinges on the es-
tablishment of the assay's variability.
Magnesium is the second most abundant cation found in
the intracellular fluid and the fourth most abundant cati-
on in the extracellular fluid [1]. It is a cofactor for more
than 325 enzymatic reactions including adenosine tri-
phosphate (ATP) metabolism, glucose utilization, muscle
contraction and synthesis of fat, protein, and nucleic acids
[2]. It is also involved in intermediary metabolism, neu-
romuscular activity, secretion, excitation-secretion cou-
pling, cardiovascular health and bone metabolism [3].
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A number of disease states have been associated with mag-
nesium imbalances and include: cardiovascular diseases,
neuromuscular disorders, higher mortality rates [4], renal
diseases, drug toxicities, asthma [5], migraines, premen-
strual syndrome, pre-eclampsia, eclampsia, menopausal
bone problems [3], atherosclerosis, diabetes mellitus,
obesity [6], and hypertension [7]. As well, Lukaski [8] has
noted a decrease in athletic performance as a result of
magnesium deficiency/imbalances.
Low dietary intakes of Mg may account for low Mg status
in many individuals. Altura [9] found that dietary intakes
of magnesium in the United States have been declining
since the turn of the century from about 500 mg/day to
175–225 mg/day. According to the National Research
Council of Canada, [10], this is due to the increasing use
of fertilizers (lacking Mg) and food processing (removing
Mg). Some investigators believe that the current RDA of
350 mg/day for men and 300 mg/day for women as rec-
ommended by the US National Academy of Sciences is
too low and should be 450–500 mg/day [11].
According to Djurhuus et al., [6] there is no consensus re-
garding measurement of magnesium. Although muscle
Mg, obtained through a needle biopsy, is thought to be re-
liable, it is time consuming to perform, very invasive and
causes discomfort to the patient. Magnesium status can
also be measured in the serum, erythrocytes, and lym-
phocytes or through a magnesium load test with urinary
excretion [6]. However, Djurhuus et al., [6] have found
that urinary Mg is quite variable, so generally it cannot be
used to evaluate Mg status. The total amount of Mg in se-
rum (TMg) is the most common means for measuring
magnesium status. Although TMg has been the most com-
mon measure for magnesium status, since the introduc-
tion of the ISE for Mg, ionic Mg has been widely used and
may become the new standard.
There is approximately 1000 mmol of magnesium in the
human body [12], with muscle and bone comprising ap-
proximately 80% of total body Mg [6]. The serum portion
of blood contains less than 1 percent, yet is the most ac-
cessible source for Mg measurement. Serum Mg can fur-
ther be subdivided into its component parts: ionic,
complex-bound, and protein-bound. It is the free (ionic)
portion, however, that is most important because it is
physiologically active [13]. Ionic magnesium levels have
been found by Altura & Altura, [5] to be altered in some
disease states and should prove to be of importance in dis-
ease management.
Despite the clinical advantages that iMg has to offer, its
usefulness may be compromised by physiological varia-
bility. Studies have shown a circadian rhythm associated
with TMg as well as iMg. In 1978, Touitou et al.[12] found
a significant circadian rhythm in TMg. As well, Willimzig,
Latz, Vierling & Mutschler [14] found a noticeable circadi-
an fluctuation of TMg with a peak in evening hours and
strong fluctuations in the morning. Ising, Bertschat,
Gunther, Jeremias & Jeremias [15] were the first to discov-
er a significant circadian rhythm in iMg and observed the
highest concentrations around 9:00 and the lowest con-
centrations around 15:00. A further study relating to the
discoveries by Ising et al., [15] was conducted by Jacomel-
la et al., [16] to see if glucose loading affected the circadian
rhythm of iMg and found no significant results.
Although assessment of iMg would appear to have obvi-
ous clinical and research implications in the screening,
monitoring, diagnosis and treatment of individuals, de-
termination of an intra-individual variability would con-
found appropriate interpretation of iMg values. This
variability has only been hinted at in previous research
[12,14–17]. Knowledge of these changes over time is vital
to the collection of specimens at appropriate times, selec-
tion of relevant reference values, and in diagnosis, because
the absence of the expected rhythm may indicate the pres-
ence of disease [18]. This research thus represents a critical
step in the validation of iMg measurements. If iMg proves
to be variable, the nature and physiological mechanisms
underlying the variance would need to be determined.
Results
Participants' self-report journals revealed that no unfore-
seen circumstances occurred during the three days of test-
ing. All subjects maintained normal routines of exercise
and lifestyle (work, diet, and sleep), with no unexpected
changes in their daily routines (other than the six blood
samples per day).
The mean dietary magnesium intakes were 378.2 +/-
157.7 mg/day. The dietary analyses showed that four sub-
jects (two males and two females) had intakes less than
the RDA of 350 mg/day for men and 300 mg/day for
women, with both above mentioned male subjects having
less than 70% of the RDA. Values over 70% of the RDA are
in the acceptable range for adequate nutrition [8].
Mean iMg values and ranges are presented in Figure 1.
Nine of the thirteen subjects (69.2%) recorded at least one
value below the reference range (0.46 – 0.60 mmol/L)
suggested by Ising et al., [15]. The highest value recorded
(0.56 mmol/L) was reached by two subjects.
The CVt, CVa, CVi and index of individuality ratios are in-
dicated in Table 2. The total variability had a mean of
4.3% and ranged from 3.1 to 7.2%. The estimated analyt-
ical variability was 2.3%. The mean physiologic or "true"
biological variance of iMg was thus a CVi of 2.0%. The av-
erage index of individuality was .88.BMC Physiology 2002, 2 http://www.biomedcentral.com/1472-6793/2/6
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A representative subject's iMg values over the three days
are shown in Figure 2. Initial plotting of all of the subject's
iMg data revealed the possibility of an inherent rhythm to
the data. Mean values for the six time periods of data col-
lection as well as the corresponding coefficients of varia-
tion (CV) are shown in Table 3.
Within-day and between-day variability
A 3 (Day: 1,2,3) by 6 (Time: 7:00, 10:00, 13:00, 16:00,
19:00, 22:00) repeated measures analysis of variance
(ANOVA) was calculated on the iMg values. There was a
significant main effect for time (F(5,2) = 6.71, p < 0.001).
The main effect for day was not significant (F(2,5) = 2.07,
p = 0.142). However, there was a significant interaction (F
= 6.71, p < 0.001).
As noted, plotting the data across time points in a given
day for a given subject indicated that there was an inher-
ent rhythm for the measured variable. Therefore data was
transformed and slope scores were used in the subsequent
ANOVA. A non-significant result was obtained for the be-
tween-day variation (F(2,12) = 0.915, p = 0.557).
Discussion
The key finding of this study is that iMg is not variable
from day to day, yet is variable in healthy subjects over the
course of one day. The within-day variability is illuminat-
ed in the descriptive statistics, a partitioning of variability
components (Table 2) and the repeated-measures ANO-
VA statistic. In figure #1 for example, participant #1 exhib-
ited a range in iMg from .42 to .56 mmol/L. The .42 value,
recorded at 10:00 AM on day 3 would put her in a hy-
pomagnesemic state, whereas the .56 mmol/L value, re-
corded at 10:00 PM on day 1 places her in the upper
normal range. Less drastic ranges were observed in the
other subjects but nevertheless, the clinical implications
in basing a diagnosis or treatment on a single measure-
ment are significant. Another problem is that the diurnal
rhythms noted are somewhat variable from one individu-
al to another, so that no particular time represents a uni-
versal maximum or minimum.
Partitioning of variability
It is essential to obtain separate estimates of the individual
(CVi) and analytical (CVa) components of variability that
make up the total (CVt). Analytical variability was deter-
mined to be a CV of 2.3%. This value exceeds the criterion
noted by Fraser and Harris [18], which states that the max-
imum allowable analytical variation should be less than
or equal to half the average within-subject variation. The
average within subject variability was 2.0%. On the other
hand a CV of 2.3% is less than a 3% value considered ac-
ceptable by Nova Biomedical®. While analytical variability
may be pushing or beyond acceptable limits, 47% (or 2.0/
4.3) of the total variability of iMg is due to "true" physio-
logical variance.
Within-day and between-day variability
Observing a within-day variability provides essential in-
formation for clinical interpretation of iMg. The data indi-
cate that there are specific peaks of iMg concentration as
well as troughs, and that these fluctuations follow a diur-
nal rhythm. The discrepancy between consecutive blood
samples (7:00 and 10:00) indicates that iMg may not be a
suitable means of diagnosing Mg status. A patient in a
clinic may show a normal ionic magnesium level if tested
at 7:00 but could be deficient if tested again at 10:00.
More research in this area is needed for a better under-
standing of within-day iMg variability. The findings of the
present study are consistent with Ising et al., [15] who
found a maximum value in the morning and a minimum
value later in the day.
Coefficients of variation (CV) were calculated for the com-
bined set of blood samples taken during each time period
which showed that the lowest variation (3.9%) occurred
during the first blood sample (7:00), while the second,
fourth and sixth blood samples (10:00, 16:00, and 22:00)
had the highest CV at 5.2%, which suggests that the best
time for blood collection is first thing in the morning.
These results are in agreement with Fraser & Harris [18]
who reported that the ideal method for specimen sam-
pling is to collect the specimen from fasting, non-exer-
cised subjects between 7:00 and 9:00.
A non-significant between-day variability is important to
the utility of iMg as a reliable means of measuring Mg sta-
tus, as it shows that multiple samples when converted to
sinusoidal data for each day for three consecutive days
will not significantly vary. This will add confidence to the
clinician when measuring iMg in hospitalised patients, as
stability can be monitored successfully from day to day, or
more importantly when values are changing daily and are
no longer stable. It should be kept in mind though that
the total duration of this study was only three days. Many
analytes show cyclical rhythms, which can be circadian,
monthly, or seasonal in nature [17].
Table 1: Characteristics of participants
Parameter Mean +/- S.D. Range
Age (yrs) 24.8 +/- 5.7 21 – 41
Height (cm) 173.5 +/- 8.7 165.5 – 184.0
Weight (kg) 67.1 +/- 12.5 47.7 – 89.3
Systolic Blood Pressure (mmHg) 115.3 +/- 8.2 103 – 125
Diastolic Blood Pressure (mmHg) 72.9 +/- 8.2 58 – 80
Dietary Mg Status (mg/day) 378.2 +/- 157.7 132 – 533BMC Physiology 2002, 2 http://www.biomedcentral.com/1472-6793/2/6
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Circadian rhythm
There are a number of reasons that could explain the dis-
covered within-day variability, including analytical error
or biological variability perhaps due to exercise, diet,
stress or circadian rhythm. Speculation on causal factors
that could explain iMg variability must be guarded as nei-
ther the purpose nor design of this study was geared to-
ward causality. The possibility of a circadian rhythm has
been found in previous research [15] and could explain
the biological variability found in the subjects in this
study. A preliminary examination of plotted individual
data showed an inherent rhythm to the data. However,
when all data was pooled together and smoothed to a si-
nusoidal curve of best fit, the data no longer showed a
rhythm to it. Therefore, a circadian rhythm may be evi-
dent in each individual, which may explain the significant
within-day variability. Also, as mentioned above, exercise
and diet were not controlled throughout the study, which
may influence the results. The fact that biological variabil-
ity of iMg does exist but many biological causes are not
controlled for in a clinical setting, points to the pressing
need for more research along these lines.
Index of Individuality
In order to assess the utility of iMg values, an index of in-
dividuality was calculated. When the index of individual-
ity is expressed as CVt/CVg, is less than 0.6, conventional
population-based reference values are of very limited di-
agnostic value [18]. On the other hand though, a low in-
dex of individuality means that the indice being measured
could find value in the tracking of a disease progression or
the effectiveness of the treatment. In contrast, when CVt/
CVg is more than 1.4, observed values can be compared
usefully with reference values [18]. With an average ratio
of .88, neither conclusion can be drawn. In other words
caution is warranted in comparing iMg values to reference
ranges and in tracking an individual's values.
The means and ranges of iMg (Figure 1) indicate that the
reference range suggested by Ising et al., [15] is not useful
with respect to each individual. Each subject's range falls
on the low end of the spectrum, yet compared to other
population-based reference ranges, this is one of the rang-
es with lower values. The individual ranges would fall
completely out of some other population-based ranges.
Therefore, the need for subject-based reference intervals
may be necessary.
Magnesium status
Although measurement of the variability of iMg was the
focus of the study, Mg status is also very important, as iMg
is a means for determining total body magnesium status.
Using the reference range by Ising et al. [15] (0.46 – 0.60
mmol/L) and the values obtained from the present study,
one is able to determine the status of each subject. The
mean values for each subject (18 samples) revealed that
one subject rests on the border of Mg deficiency (O.46
mmoI/L) while all other subjects have normal mean iMg
values but are on the low end of the range (highest indi-
vidual mean is O.52 mmol/L). Throughout the three days
of testing, however, nine of the subjects recorded one or
more value below the reference range and would be con-
sidered hypomagnesemic. The results of the diet analyses
revealed that only two subjects had intakes of dietary Mg
below 70% of the RDA, thus suggesting that diet may not
be the cause of the low iMg values. One explanation could
be that the NOVA® instrument gives low values (com-
pared to other instruments). This suggestion can be dis-
counted though for testing of control samples of known
iMg concentrations were always within acceptable ranges.
A more likely explanation is that most published reference
ranges for iMg are inappropriate, since all subjects were
healthy individuals.
Figure 1
Means and ranges of iMg in 13 healthy individuals
iM g (m mol/ L)
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Greenway et al. [4] proposed that to use iMg as a valid bi-
ochemical marker, it is essential to establish a reliable ref-
erence interval in a healthy population. Close
examination of previous studies that determined refer-
ence ranges for iMg has shown that wide spectrums of
ranges have been developed. This may be due to the lack
of partitioning that has been reported (for example for
age, blood group, gender, race, time of day or posture
when sampled) and possibly due to the differences
among the three different companies and the ISE that they
use.
Conclusions
This study concluded that there is a significant within-day
variation in iMg (six blood samples per day taken every
three hours from 7:00 till 22:00) and a non-significant be-
tween-day variation (three consecutive days of sampling).
The significant within day variability of iMg should be ac-
counted for in clinical and research settings and caution
should be used in interpreting single measurements. A
plausible explanation of the data is that iMg has a circadi-
an rhythm.
Materials and Methods
Description of Participants
The characteristics of the 13 participants (nine males and
four females) that volunteered for the study are listed in
table 1. Participant selection for this study was based
largely on volunteers who were willing to donate 18
blood samples over three days, but participants were also
screened for smoking (non-smokers), blood pressure
(resting blood pressure not higher than 144/94), drug use
(prescription and non-prescription), vitamin and/or min-
eral use. As well, alcohol consumption was not permitted
throughout the duration of the study.
The Lakehead University ethics committee approved the
study. After informed consent was obtained from each
subject, three consecutive days of testing occurred with six
blood samples taken each day for a total of eighteen blood
samples. The first blood sample was taken at 7:00 a.m.
and every three hours thereafter (7:00, 10:00, 13:00,
16:00, 19:00, 22:00). Blood samples were collected
throughout the study in 7 ml green topped Vacutainer®
tubes (lithium-heparin added) by antecubital venipunc-
ture. Prior to blood withdrawal, the subjects were seated
for ten minutes. When blood was collected, a tourniquet
was applied gently to the upper arm and released prior to
actual blood flow.
The Nova 8 stat analyzer® (Nova Biomedical Canada Ltd.,
Mississauga, Ontario) housed in the same laboratory that
testing occurred, was used for immediate analysis of [iMg]
and Hct, from whole blood samples. Throughout the
study, the same technician did all the testing. Within-run
variation or CVa (analytical error) was calculated by repli-
cate analysis of the specimens (i.e., ten samples in a row
of the same blood). Between run variability was not re-
corded, although control samples in the normal physio-
logical range were consistently within +/- 1 mmol/L of
their known concentration.
During the three days of testing, subjects recorded diet,
sleep, exercise and stress in a self-monitored logbook.
Subjects received information that explained the proce-
dure and importance of accuracy for the self-reported logs
and were instructed to continue to follow their normal
routine as close as possible.
Dietary intakes were analysed using computerised diet
software (Diet Analysis Plus®, 1996, West Publishing Co,
St. Paul, MN). Subjects recorded three consecutive days of
testing (the same days as the blood samples – two week-
days and one weekend day) and all data was entered into
the computer by the same technician.
Daily Log
The variables included in the daily log include: (1) Qual-
ity of sleep, (2) Number of hours of sleep, (3) length of ex-
ercise session, (4) intensity of exercise session, (5) minor
illnesses, (6) minor injuries, (7) menstruation, and (8)
major stressful events.
Table 2: Partitioning of the variability and index of individuality
Subject CVt CVa CVi CVt/CVg
1 7.2 2.3 4.9 1.47
2 3.8 2.3 1.5 .77
3 4.1 2.3 1.8 .84
4 3.2 2.3 0.9 .65
5 4.1 2.3 1.8 .83
6 4.8 2.3 2.5 .97
7 3.1 2.3 0.8 .63
8 4.8 2.3 2.5 .97
9 4.4 2.3 2.1 .90
10 3.7 2.3 1.4 .76
11 3.8 2.3 1.5 .78
12 5.6 2.3 3.3 1.14
13 3.6 2.3 1.3 .73
MEAN 4.3 2.3 2.0 .88
*Coefficient of Variability (CV) for total (t), analytical (a) and individual 
(i) variability expressed in percentages. An index of individuality (CVt/
CVg) where CVg is the between-subject variability is also shown. CVg 
was determined to be 4.9%.BMC Physiology 2002, 2 http://www.biomedcentral.com/1472-6793/2/6
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Dependent Variables
(1) Ionic magnesium (mmol/L) – corrected for hemat-
ocrit
(2) Hematocrit (%)
Independent Variables
(1) Time
(2) Day
Statistical Analysis
The primary purpose of this study was to determine the
variability of iMg in order to determine its utility. Descrip-
tive statistics (mean, standard deviation, range and coeffi-
cient of variation (CV)) and graphic presentations of the
data were used to gain an initial appreciation of the varia-
bility of iMg. CVs were computed to assess analytical error
(CVa) from ten repeated measures of subject samples
(subjects as their own control). Total within-subject vari-
ability (CVt) was computed for each subject's 18 samples
with the difference between CVa and CVt attributable to
biological variability (CVi). To calculate the CV for the six
time periods, all blood values obtained at each time peri-
od were pooled together (13 subjects ×  3 days = 39 val-
ues). The average CV for the six time periods constituted
the CVg or between-subject variability. An index of indi-
viduality was calculated using a ratio of the total within-
subject variability and the between-subject variability
(CVt/CVg), in order to assess the utility of iMg in either
monitoring a patient or classifying them based on refer-
ence ranges.
A 13 (subjects) ×  6 (time periods) repeated measures anal-
ysis of variance (ANOVA) was used to calculate the with-
in-day variability. Calculation of the between-day analysis
requires a data transformation to provide a score for each
subject that represents the events of each day across each
time measurement. It is important to recognise that the
score must consider the events within the measurement
interval as a function of events in the preceding interval
but while impacting events in each subsequent interval.
Plotting the data across time points in a given day for a
given subject indicated that there was an inherent rhythm
for the measured variable. Therefore, a linear (summa-
tive) transformation was inappropriate for the data. A
summative scalar such as the coefficient of variation
(standard deviation/mean) only considers the range of
the variance distributed over the group mean, thus, a
transformation that considers range as well as rhythmicity
of responses over the entire collection period was needed.
Considering the above, the raw data was transformed us-
ing a cosine function (transformed score = 1/2 sin (raw
score)). The slope of the transformed data curve was then
calculated for each subject, for each day, and the slope
scores used in a subsequent ANOVA across the three days.
The first two authors, I.J. Newhouse and K.P. Johnson
contributed equally to the preparation of this manuscript.
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